Psychiatry & Neurology Doctors in Warrington, PA Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Jeffrey David Gould, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 847 Easton Rd Ste 2700, Warrington, PA 18976 Phone: 215-345-0105    Fax: 215-345-0562

Dr. Taslim Zaman, DO Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1432 Easton Rd Ste 5a&5b, Warrington, PA 18976 Phone: 484-685-0965    Fax: 215-792-7855

Carly Scatton, D.O. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 847 Easton Rd Ste 2700, Warrington, PA 18976 Phone: 215-345-0105    Fax: 215-345-0562

Dr. David Allen Nover, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1432 Easton Rd, Suite 2-c, Warrington, PA 18976 Phone: 215-491-7570    Fax: 215-491-2300

Dr. Anowar Hossain, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 847 Easton Rd Ste 2700, Warrington, PA 18976 Phone: 215-345-0105    Fax: 215-345-0562

News Archive

Preliminary study results of ExThera Medical's Seraph extracorporeal affinity therapy published

ExThera Medical announced today that the results of a preliminary study ("Cytokines in blood from septic patients interact with surface immobilized heparin") of its proprietary medical device, Seraph™ extracorporeal affinity therapy, have been published in the current issue of the Journal of the American Society for Artificial Organs (Jan.-Feb. 2010).

Genetic differences influence asthma risk in Latinos

Native American ancestry is associated with a lower asthma risk, but African ancestry is associated with a higher risk, according to the largest-ever study of how genetic variation influences asthma risk in Latinos, in whom both African and Native American ancestry is common. The study, led by UC San Francisco researchers, was published online October 6, 2014 in the Journal of Allergy and Clinical Immunology.

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

UCB and sanofi-aventis have announced that the U.S. Food and Drug Administration (FDA) approved a New Drug Application (NDA) for XYZAL (levocetirizine dihydrochloride) 0.5 mg/mL oral solution, a prescription antihistamine indicated for the relief of symptoms associated with indoor and outdoor allergies, as well as the treatment of chronic idiopathic urticaria.

Increased awareness of fertility preservation options needed for young patients with cancer

A new study points to the need for increased awareness of fertility preservation options for young patients with cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that factors such as gender, education, and insurance status may impact whether patients and their physicians have discussions and take actions to preserve fertility during cancer treatment.

BioJapan 2010 announces 'Renaissance of Bioindustry' as main theme

BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.

Read more Medical News

› Verified 4 days ago